TransIT-X2® Universal transfection solution

TransIT-X2 ® Universal transfection solution

fromMirusStar products launched through research and developmentTransIT-X2®Transfection reagents combine multifunctionality and high performance, with efficient adaptability to both broad-spectrum and difficult to transfect cells. They can effectively avoid tedious condition optimization and repeated experiments, significantly improving experimental efficiency and result reliability.

New technology: excellentLPNCComposite formula

MirusAbandoning the traditional single component model and relying on polymers/Lipid multidimensional hybridization technology constructs a multi-dimensional transfection scheme in a non liposome nanostructure system, effectively overcoming multiple intracellular delivery barriers and significantly improving transfection efficiency while significantly reducing cell toxicity.

TransIT-X2®Having efficient operational procedures

TransIT-X2®No need for complex preprocessing, significantly reducing the transfection operation time, and shortening the entire process from complex preparation to sample loading, greatly improving experimental efficiency.

TransIT-X2®Product advantages and features

TransIT-X2®Has broad-spectrum high efficacy

TransIT-X2®Capable of broad-spectrum transfection efficiency, in41In the comparative experiment of different cell lines 36 Achieved luciferase expression superior to or equivalent to common liposome transfection reagents in seed cell lines; among which17The expression level of seed cell lines is higher than that of common liposome transfection reagents2More than double.

TransIT-X2®Has very low cytotoxicity

TransIT-X2®The dynamic delivery system is superior to common liposome transfection reagents. inA549andMDCKIn cells, they are used separatelyTransIT-X2®Transfection of luciferase plasmid with common liposome transfection reagents（24 h）. By detecting the transfection efficiency through luciferase activity,LDHEvaluate cytotoxicity using the release method.The results indicate that under appropriate ratios,TransIT-X2®compareCommon Liposome Transfection ReagentsSignificantly enhance the expression of exogenous genes and reduce cell toxicity.

TransIT-X2®Has broad compatibility

TransIT-X2®Can simultaneously transfect nucleic acids and proteins. Including but not limited toDNAThesiRNA/miRNAandCRISPR/Cas9compound. The transfection process does not require the replacement of serum-free culture medium and can be directly performed in serum-containing culture medium, simplifying the operation steps and reducing stress on cells.

TransIT-X2 ® Universal transfection solution

TransIT-X2®Order Information

Bonus at the end

Follow Ximeijie's WeChat official account“xmjsci”Reply to keywords“X2trial”And fill out the application form to apply for collection100 μL TransIT-X2®Transfection reagent trial kit. After approval, the applicant can further enjoy exclusive purchasing discounts for formal wear products. Welcome all researchers to apply for experience!

Mirus Bioestablished in1995Nian is one of the early companies in the world to develop efficient and low toxicity transfection reagents, and is currently one of the main suppliers of such reagents.MirusWith multiple groundbreaking achievements, it has won a wide international reputation and long-term trust from scientific research users.Beijing Ximeijie Technology Co., Ltd. isMirusThe agent in China always adheres to a professional and rigorous attitude to provide customers with high-quality products and services. Beijing Ximeijie is Mirus agent, Mirus China agent, Mirus Beijing agent, Mirus general agent, Mirus Shanghai agent, ， Mirus Northwest Agent, Mirus Southwest Agent, Mirus Northeast Agent, Mirus North China Agent, Mirus South China Agent, Mirus Central China Agent, responsible for Mirus' related business in China.